Rapid COVID Antibody Test Can Reveal Immune Status in 15 Minutes

As of July 2021, the number of hospitalisations and deaths due to COVID-19 have significantly dropped since the second peak around January this year. In addition to restrictions, the greatest contributor to this drop has been the rapid vaccine uptake...

3 years ago
Biology

Rapid COVID Antibody Test Can Reveal Immune Status in 15 Minutes

As of July 2021, the number of hospitalisations and deaths due to COVID-19 have significantly dropped since the second peak around January this year. In addition to restrictions, the greatest contributor to this drop has been the rapid vaccine uptake...

3 years ago

COVID-19 Booster Controversy: Disputes Across the Pharma Industry

Despite almost two thirds of the adult population in the UK having been vaccinated, cases are on the rise, which appear to be associated with the highly-transmissible delta variant of COVID-19. According to The European Centre for Disease Prevention and Control,...

3 years ago
Biology,News

COVID-19 Booster Controversy: Disputes Across the Pharma Industry

Despite almost two thirds of the adult population in the UK having been vaccinated, cases are on the rise, which appear to be associated with the highly-transmissible delta variant of COVID-19. According to The European Centre for Disease Prevention and Control,...

3 years ago

RNA Therapeutics: Innovations in Disease Research and Drug Development

RNA has proven in the last decade to be a valid therapeutic target for a multitude of diseases. The ability to manipulate the genetic code to produce almost any protein is one of the many advantages that has also led...

3 years ago
R&D,Biology

RNA Therapeutics: Innovations in Disease Research and Drug Development

RNA has proven in the last decade to be a valid therapeutic target for a multitude of diseases. The ability to manipulate the genetic code to produce almost any protein is one of the many advantages that has also led...

3 years ago

Emerging Innovations in Translational Medicine: An Interview with Marcie Glicksman, Enclear Therapies

3D cultures and organ-on-a-chip are a few examples of technologies that hope to bridge the gap from benchside to clinic. Failures that arise during drug development often arise due to poor translatability from models in preclinical studies to the patients...

3 years ago
R&D,Biology

Emerging Innovations in Translational Medicine: An Interview with Marcie Glicksman, Enclear Therapies

3D cultures and organ-on-a-chip are a few examples of technologies that hope to bridge the gap from benchside to clinic. Failures that arise during drug development often arise due to poor translatability from models in preclinical studies to the patients...

3 years ago

Drugs in Space: How Extraterrestrial Experiments Help Us Develop Medicine

Over the last 20 years, fundamental scientific research has been conducted by astronauts aboard the international space station (ISS). It has only been recently that the pharmaceutical and biotech sectors have invested in extraterrestrial experiments, hoping to find novel ways...

3 years ago
R&D,Biology

Drugs in Space: How Extraterrestrial Experiments Help Us Develop Medicine

Over the last 20 years, fundamental scientific research has been conducted by astronauts aboard the international space station (ISS). It has only been recently that the pharmaceutical and biotech sectors have invested in extraterrestrial experiments, hoping to find novel ways...

3 years ago

COVID-19 Booster Controversy: Disputes Across the Pharma Industry

Despite almost two thirds of the adult population in the UK having been vaccinated, cases are on the rise, which appear to be associated with the highly-transmissible delta variant of COVID-19. According to The European Centre for Disease Prevention and...

3 years ago
Biology

COVID-19 Booster Controversy: Disputes Across the Pharma Industry

Despite almost two thirds of the adult population in the UK having been vaccinated, cases are on the rise, which appear to be associated with the highly-transmissible delta variant of COVID-19. According to The European Centre for Disease Prevention and...

3 years ago

Addressing the Challenges of CNS Drug Delivery

Diseases of the central nervous system (CNS) represent one of the most complex groups of conditions in the world. Developing therapeutics that treat diseases of the brain especially has been an uphill struggle in terms of optimising drug delivery systems....

3 years ago
Biology

Addressing the Challenges of CNS Drug Delivery

Diseases of the central nervous system (CNS) represent one of the most complex groups of conditions in the world. Developing therapeutics that treat diseases of the brain especially has been an uphill struggle in terms of optimising drug delivery systems....

3 years ago

The Latest Advancements in Immuno-oncology: Checkpoint Inhibitors

Until now, patients with advanced cervical cancer had relatively low survival rates. The recent approval of Keytruda, a PD-1/PD-L1 checkpoint inhibitor, is the latest breakthrough for cervical cancer immunotherapy. The positive outcome from Merck & Co’s clinical trial now offers...

3 years ago
Oncology,Biology,News

The Latest Advancements in Immuno-oncology: Checkpoint Inhibitors

Until now, patients with advanced cervical cancer had relatively low survival rates. The recent approval of Keytruda, a PD-1/PD-L1 checkpoint inhibitor, is the latest breakthrough for cervical cancer immunotherapy. The positive outcome from Merck & Co’s clinical trial now offers...

3 years ago

The Potential of Therapeutic Psychedelics Drugs: An Interview with Professor Albert Garcia-Romeu

Mental health conditions like addiction and diseases like Alzheimer’s represent a great unmet clinical need. Psychedelic research at preclinical stages have shown potential for positive neurological changes in the brain for models of depression, addiction and Alzheimer's. In a recent...

4 years ago
R&D,Precision and Personalised Medicine,Biology,News

The Potential of Therapeutic Psychedelics Drugs: An Interview with Professor Albert Garcia-Romeu

Mental health conditions like addiction and diseases like Alzheimer’s represent a great unmet clinical need. Psychedelic research at preclinical stages have shown potential for positive neurological changes in the brain for models of depression, addiction and Alzheimer's. In a recent...

4 years ago

Challenges and Opportunities in Pharmaceutical Manufacturing

The rapid change in demand for pharmaceutical products during the COVID-19 pandemic sent shockwaves throughout the industry. Since the start of the crisis, pharma manufacturers have implemented a number of innovations to streamline the production process from start to finish....

4 years ago
Biomanufacturing,Biology

Challenges and Opportunities in Pharmaceutical Manufacturing

The rapid change in demand for pharmaceutical products during the COVID-19 pandemic sent shockwaves throughout the industry. Since the start of the crisis, pharma manufacturers have implemented a number of innovations to streamline the production process from start to finish....

4 years ago